Literature DB >> 9773763

Psychosocial factors influencing the short-term outcome of antithyroid drug therapy in Graves' disease.

K Yoshiuchi1, H Kumano, S Nomura, H Yoshimura, K Ito, Y Kanaji, T Kuboki, H Suematsu.   

Abstract

OBJECTIVE: Although psychological stress and smoking have been proposed as factors contributing to Graves' disease, their independent roles in the course of this disease have not been determined. We assessed the association between the course of Graves' disease and psychosocial factors by using multivariate analysis.
METHODS: We investigated the association between the short-term outcome of Graves' disease (assessed 12 months after the beginning of antithyroid drug therapy) and stressful life events, daily hassles, smoking, drinking habits, coping skills, and social support (before and 6 months after beginning therapy) in 230 patients (182 women and 48 men) with newly diagnosed Graves' disease, using a logistic regression model.
RESULTS: After adjustment for smoking, coping skills, and thyroid function, daily hassles scores in women at 6 months after beginning therapy were significantly associated with a hyperthyroid state 12 months after beginning therapy. The relative risk was 3.9 for women with higher daily hassles scores compared with women with lower daily hassles scores (95% confidence interval, 1.1 to 13.2; p < .05). Smoking was not significantly associated with a hyperthyroid state 12 months after beginning therapy in either women or men.
CONCLUSIONS: Chronic psychological stress is associated with the course of Graves' disease in women.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773763     DOI: 10.1097/00006842-199809000-00014

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  8 in total

Review 1.  [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

Authors:  A Eckstein; J Esser
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

2.  Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

3.  [Endocrine ophthalmopathy. A visible psychophysical complaint].

Authors:  I Strempel
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

4.  A patient with stress-related onset and exacerbations of Graves disease.

Authors:  Roberto Vita; Daniela Lapa; Giuseppe Vita; Francesco Trimarchi; Salvatore Benvenga
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-25

5.  Stress and hormones.

Authors:  Salam Ranabir; K Reetu
Journal:  Indian J Endocrinol Metab       Date:  2011-01

6.  The thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment.

Authors:  Atsushi Fukao; Junta Takamatsu; Sumihisa Kubota; Akira Miyauchi; Toshiaki Hanafusa
Journal:  Biopsychosoc Med       Date:  2011-08-09

Review 7.  Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence.

Authors:  Jia Liu; Jing Fu; Yuan Xu; Guang Wang
Journal:  Int J Endocrinol       Date:  2017-04-25       Impact factor: 3.257

Review 8.  Graves' disease and mental disorders.

Authors:  Atsushi Fukao; Junta Takamatsu; Takeshi Arishima; Mika Tanaka; Toshio Kawai; Yasuki Okamoto; Akira Miyauchi; Akihisa Imagawa
Journal:  J Clin Transl Endocrinol       Date:  2019-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.